期刊文献+

Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies 被引量:11

Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies
下载PDF
导出
摘要 Cancer cells are well documented to rewire their metabolism and energy production networks to support and enable rapid proliferation, continuous growth, survival in harsh conditions, invasion, metastasis, and resistance to cancer treatments. Since Dr. Otto Warburg's discovery about altered cancer cell metabolism in 1930, thousands of studies have shed light on various aspects of cancer metabolism with a common goal to find new ways for effectively eliminating tumor cells by targeting their energy metabolism. This review highlights the importance of the main features of cancer metabolism, summarizes recent remarkable advances in this field, and points out the potentials to translate these scientific findings into life-saving diagnosis and therapies to help cancer patients. Cancer cells are well documented to rewire their metabolism and energy production networks to support and enable rapid proliferation, continuous growth, survival in harsh conditions, invasion, metastasis, and resistance to cancer treatments. Since Dr. Otto Warhurg's discovery about altered cancer cell metabolism in 1930, thousands of studies have shed light on various aspects of cancer metabolism with a common goal to find new ways for effectively eliminating tumor cells by targeting their energy metabolism. This review highlights the importance of the main features of cancer metabolism, summarizes recent remarkable advances in this field, and points out the potentials to translate these scientific findings into life-saving diagnosis and therapies to help cancer patients.
出处 《Cancer Biology & Medicine》 SCIE CAS CSCD 2014年第1期1-19,共19页 癌症生物学与医学(英文版)
基金 supported by the National Institutes of Health through The University of Texas MD Anderson Cancer Center’s Support Grant CA016672 National Cancer Institute grant RO1CA 089266 (MHL) Directed Medical Research Programs Department of Defense Synergistic Idea Development Award BC062166 (SCY, MHL) the Susan G.Komen Breast Cancer Research Foundation Promise Grant KG081048 (SCY, MHL) Vietnam Education Foundation, Rosalie B.Hite Foundation Department of Defense Breast Cancer Research Program (Award # W81XWH-10-0171)
关键词 物质代谢 癌症患者 重编程 抗肿瘤治疗 疗法 抗癌 瞄准 肿瘤细胞 Cell cycle energy metabolism glycolysis glutaminolysis mitochondria biogenesis
  • 相关文献

参考文献8

  • 1Varman T. Samuel,Gerald I. Shulman.Mechanisms for Insulin Resistance: Common Threads and Missing Links[J].Cell.2012(5)
  • 2Patrick S. Ward,Craig B. Thompson.Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate[J].Cancer Cell.2012(3)
  • 3Claudio R. Santos,Almut Schulze.Lipid metabolism in cancer[J].FEBS Journal.2012(15)
  • 4Chiara Riganti,Elena Gazzano,Manuela Polimeni,Elisabetta Aldieri,Dario Ghigo.The pentose phosphate pathway: An antioxidant defense and a crossroad in tumor cell fate[J].Free Radical Biology and Medicine.2012(3)
  • 5Douglas Hanahan,Robert A. Weinberg.Hallmarks of Cancer: The Next Generation[J].Cell.2011(5)
  • 6Rajat Singh,Ana Maria Cuervo,Anne Simonsen.Lipophagy: Connecting Autophagy and Lipid Metabolism[J].International Journal of Cell Biology.2012
  • 7Anne Le,Andrew N. Lane,Max Hamaker,Sminu Bose,Arvin Gouw,Joseph Barbi,Takashi Tsukamoto,Camilio J. Rojas,Barbara S. Slusher,Haixia Zhang,Lisa J. Zimmerman,Daniel C. Liebler,Robbert J.C. Slebos,Pawel K. Lorkiewicz,Richard M. Higashi,Teresa W.M. Fan,Chi V. Dang.Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells[J].Cell Metabolism.2012(1)
  • 8Gregg L. Semenza.Hypoxia-Inducible Factors in Physiology and Medicine[J].Cell.2012(3)

同被引文献20

  • 1李娟,王金环,伏志,侯维,王馨,于红卫,冯岩梅,孟庆华,卢实春.终末期肝病患者肝移植前后的能量代谢特点[J].中国临床营养杂志,2008,16(4):228-232. 被引量:4
  • 2鲁文清,刘爱林.饮用水消毒副产物研究进展[J].癌变.畸变.突变,2007,19(3):181-183. 被引量:28
  • 3肖娟,刘选明,徐康平,颜冬兰,刘让茹,章为,谭桂山.KTDA抑制肿瘤细胞增殖和诱导凋亡的研究[J].中南药学,2007,5(5):416-419. 被引量:4
  • 4Parkin D Max,Bray Freddie,Ferlay J,Pisani Paola.Global cancer statistics, 2002. CA: a cancer journal for clinicians . 2005
  • 5Paul A.Clark,Daniel M.Treisman,JohnathanEbben,John S.Kuo.Developmental signaling pathways in brain tumor‐derived stem‐like cells[J]. Dev. Dyn. . 2007 (12)
  • 6Satoru Ozawa,Kazuhisa Uchiyama,Mikihito Nakamori,Kentaro Ueda,Makoto Iwahashi,Hikaru Ueno,Yasuteru Muragaki,Akira Ooshima,Hiroki Yamaue.Combination gene therapy of HGF and truncated type II TGF-β receptor for rat liver cirrhosis after partial hepatectomy[J]. Surgery . 2006 (4)
  • 7Lieffers Jessica R,Mourtzakis Marina,Hall Kevin D,McCargar Linda J,Prado Carla M M,Baracos Vickie E.A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. The American journal of clinical nutrition . 2009
  • 8Zhang Qi,Chen Guihua,Peng Linhui,Wang Xinghua,Yang Yang,Liu Chen,Shi Wenfang,Su Changqing,Wu Hongping,Liu Xinyuan,Wu Mengchao,Qian Qijun.Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus. Clinical cancer research : an official journal of the American Association for Cancer Research . 2006
  • 9Pineau P,Nagai H,Prigent S,Wei Y,Gyapay G,Weissenbach J,Tiollais P,Buendia M A,Dejean A.Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma. Oncegene . 1999
  • 10Thomas Seyfried.Cancer as a Metabolic Disease:On the Origin,Management,and Prevention of Cancer. . 2012

引证文献11

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部